ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer
Wei Du(Prince of Wales Hospital), S Wang(Prince of Wales Hospital), Qian Zhou(Chinese University of Hong Kong), Xiaoxing Li(Prince of Wales Hospital), Joanna Ting Wai Chu(Hong Kong Baptist University), Zai Chang(Tsinghua University), Qian Tao(Chinese University of Hong Kong), Enders K. O. Ng(Chinese University of Hong Kong), Jing‐Yuan Fang(Renji Hospital), Joseph J.�Y. Sung(Chinese University of Hong Kong), Jun Yu(Prince of Wales Hospital)
Cited by 117
Abstract
Related Papers
Cyclin D as a therapeutic target in cancer
Elizabeth A. Musgrove, C. Elizabeth Caldon, Jane Barraclough et al.|Nature reviews. Cancer|2011|1.4k
Characterization of ADAMTS-9 and ADAMTS-20 as a Distinct ADAMTS Subfamily Related to Caenorhabditis elegans GON-1
Robert Somerville, Jean‐Michel Longpré, Katherine A. Jungers et al.|Journal of Biological Chemistry|2003|325